1. Herling M, Brüggemann M, Haferlach C, Hallek M, Höller S, Hopfinger G, Stilgenbauer S, Dreger P (2022) Onkopedia [Internet]. Onkopedia Leitlinie. https://www.onkopedia.com/de/onkopedia/guidelines/t-zell-prolymphozytenleukaemie/@@guideline/html/index.html. Zugriffsdatum: 1.4.2023
2. Uptodate Review. https://www.uptodate.com/contents/clinical-manifestations-pathologic-features-and-diagnosis-of-t-cell-prolymphocytic-leukemia?csi=0484c939-bb0a-422a-b61c-a51a2671d8e0&source=contentShare. Zugriffsdatum: 1.4.2023
3. Uptodate Review und Leitlinie. https://www.uptodate.com/contents/treatment-of-t-cell-prolymphocytic-leukemia?csi=56752d18-2b8f-4f0c-ad46-2a06e88a8113&source=contentShare. Zugriffsdatum: 1.4.2023
4. Staber PB, Herling M, Bellido M, Jacobsen ED, Davids MS, Kadia TM, Shustov A, Tournilhac O, Bachy E, Zaja F, Porkka K, Hoermann G, Simonitsch-Klupp I, Haferlach C, Kubicek S, Mayerhoefer ME, Hopfinger G, Jaeger U, Dearden C (2019) Consensus criteria for diagnosis, staging, and treatment response assessment of T‑cell prolymphocytic leukemia. Blood 134(14):1132–1143. https://doi.org/10.1182/blood.2019000402
5. Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, Sempere A, Catovsky D (1991) Clinical and laboratory features of 78 cases of T‑prolymphocytic leukemia. Blood 78(12):3269–3274